Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Lanreotide, Atc H01Cb03 (Obo) For The Period 01.11.2024 - 31.10.2025 (Plus Extension Option 1X12 Months)